Aurobindo Pharma Limited — JV/Acquisition, 30-12-2025: Acquisition

Aurobindo Pharma is set to acquire up to a 26% stake in Swarnaakshu Solar Power Private Limited. This strategic investment targets securing a captive solar power source, a key move for backward integration and enhancing energy cost efficiency. The acquisition's completion is now anticipated by March 31, 2026, pending essential state government approvals for the solar power plant. This initiative underscores Aurobindo's commitment to sustainable operations and optimizing its energy footprint.